{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:57:16Z","timestamp":1791309436835,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bone.2012.11.040","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T11:45:52Z","timestamp":1354794352000},"page":"182-187","source":"Crossref","is-referenced-by-count":22,"title":["Oncogenic osteomalacia \u2014 Hypophosphataemic spectrum from \u201cbenignancy\u201d to \u201cmalignancy\u201d"],"prefix":"10.1016","volume":"53","author":[{"given":"P.","family":"Chiam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.M.","family":"Bee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"61","key":"10.1016\/j.bone.2012.11.040_bb0005","first-page":"33","article-title":"Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15years","volume":"16","author":"McCance","year":"1947","journal-title":"Q J Med"},{"key":"10.1016\/j.bone.2012.11.040_bb0010","first-page":"554","article-title":"Rickets following bone tumor","volume":"14","author":"Prader","year":"1959","journal-title":"Helv Paediatr Acta"},{"key":"10.1016\/j.bone.2012.11.040_bb0015","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"317","article-title":"Tumor-induced osteomalacia","author":"Ruppe","year":"2008"},{"issue":"3","key":"10.1016\/j.bone.2012.11.040_bb0020","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.bone.2012.11.040_bb0025","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.bone.2012.11.040_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.bone.2012.11.040_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","article-title":"Tumor-induced osteomalacia","volume":"2","author":"Drezner","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"23","key":"10.1016\/j.bone.2012.11.040_bb0040","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199406093302310","article-title":"Tumor-induced osteomalacia\u2014unveiling a new hormone","volume":"330","author":"Econs","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bone.2012.11.040_bb0045","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI115735","article-title":"Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect","volume":"89","author":"Nesbitt","year":"1992","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.bone.2012.11.040_bb0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jbmr.5650040407","article-title":"Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice","volume":"4","author":"Meyer","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.bone.2012.11.040_bb0055","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4158\/EP.14.9.1108","volume":"14","author":"Habra","year":"2008","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.bone.2012.11.040_bb0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.bone.2012.11.040_bb0065","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bone.2012.11.040_bb0070","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bone.2012.11.040_bb0075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.bone.2012.11.040_bb0080","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1210\/me.2009-0085","article-title":"Novel regulators of Fgf23 expression and mineralization in Hyp bone","volume":"23","author":"Liu","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.bone.2012.11.040_bb0085","first-page":"463","article-title":"Hypophosphatemic osteomalacia with plantar neurilemoma. A review of the literature (100 cases)","volume":"62","author":"Crouzet","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"issue":"2","key":"10.1016\/j.bone.2012.11.040_bb0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.joms.2008.01.007","article-title":"A phosphaturic mesenchymal tumor of the floor of the mouth with oncogenic osteomalacia: report of a case","volume":"67","author":"Yun","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.bone.2012.11.040_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S0022215100140551","article-title":"Oncogenic osteomalacia: case report and review of head and neck associated tumours","volume":"112","author":"Gonzalez-Compta","year":"1998","journal-title":"J Laryngol Otol"},{"issue":"4","key":"10.1016\/j.bone.2012.11.040_bb0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","article-title":"Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy","volume":"54","author":"Rhee","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.bone.2012.11.040_bb0105","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1532-5415.1993.tb06765.x","article-title":"Oncogenic osteomalacia associated with metastatic prostate carcinoma: case report and review of the literature","volume":"41","author":"McMurtry","year":"1993","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.bone.2012.11.040_bb0110","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-101-6-786","article-title":"Oncogenic osteomalacia and inappropriate antidiuretic hormone secretion due to oat-cell carcinoma","volume":"101","author":"Taylor","year":"1984","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.bone.2012.11.040_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000282746","article-title":"Prostate cancer-induced oncogenic hypophosphatemic osteomalacia","volume":"55","author":"Nakahama","year":"1995","journal-title":"Urol Int"},{"issue":"9","key":"10.1016\/j.bone.2012.11.040_bb0120","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00520-012-1474-z","article-title":"Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition","volume":"20","author":"Mak","year":"2012","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.bone.2012.11.040_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2004.09.017","article-title":"Severe hypophosphatemic osteomalacia in hormone-refractory prostate cancer metastatic to the skeleton: natural history and pitfalls in management","volume":"36","author":"Pelger","year":"2005","journal-title":"Bone"},{"issue":"7929","key":"10.1016\/j.bone.2012.11.040_bb0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bone.2012.11.040_bb0135","doi-asserted-by":"crossref","first-page":"p17","DOI":"10.1159\/000319318","article-title":"Novel PHEX gene mutation associated with X linked hypophosphatemic rickets","volume":"116","author":"Chandran","year":"2010","journal-title":"Nephron Physiol"},{"issue":"10","key":"10.1016\/j.bone.2012.11.040_bb0140","first-page":"3615","article-title":"Mutational analysis of PHEX gene in X-linked hypophosphatemia","volume":"83","author":"Dixon","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2012.11.040_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4614-0887-1_3","article-title":"FGF23 and syndromes of abnormal renal phosphate handling","volume":"728","author":"Bergwitz","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.bone.2012.11.040_bb0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder","volume":"82","author":"Econs","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2\u20133","key":"10.1016\/j.bone.2012.11.040_bb0155","first-page":"133","article-title":"Acute renal tubular dysfunction following cis-dichlorodiammine platinum therapy","volume":"11","author":"Davis","year":"1980","journal-title":"J Med"},{"issue":"8","key":"10.1016\/j.bone.2012.11.040_bb0160","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.aids.0000168985.05209.b8","article-title":"Fanconi syndrome associated with didanosine therapy","volume":"19","author":"Izzedine","year":"2005","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.bone.2012.11.040_bb0165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/ajkd.2003.50037","article-title":"Drug-induced Fanconi's syndrome","volume":"41","author":"Izzedine","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.bone.2012.11.040_bb0170","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1359\/jbmr.2004.19.5.714","article-title":"Fanconi's syndrome in HIV+ adults: report of three cases and literature review","volume":"19","author":"Earle","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"4012","key":"10.1016\/j.bone.2012.11.040_bb0175","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.174.4012.949","article-title":"Strontium induced rickets: metabolic basis","volume":"174","author":"Omdahl","year":"1971","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bone.2012.11.040_bb0180","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0272-6386(97)90207-9","article-title":"Profound hypophosphatemia and isolated hyperphosphaturia in two cases of multiple myeloma","volume":"29","author":"Dash","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.bone.2012.11.040_bb0185","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia","volume":"33","author":"Duet","year":"2008","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.bone.2012.11.040_bb0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","article-title":"Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case","volume":"36","author":"Dupond","year":"2005","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2012.11.040_bb0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4158\/EP.12.1.35","article-title":"Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy","volume":"12","author":"Hodgson","year":"2006","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.bone.2012.11.040_bb0200","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.bone.2012.11.040_bb0205","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00259-008-0755-8","article-title":"(68)Ga-DOTANOC PET\/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia","volume":"35","author":"von Falck","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.bone.2012.11.040_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0033-8389(22)01075-2","article-title":"Magnetic resonance imaging of musculoskeletal neoplasms","volume":"24","author":"Richardson","year":"1986","journal-title":"Radiol Clin North Am"},{"issue":"6","key":"10.1016\/j.bone.2012.11.040_bb0215","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2012.11.040_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002560000306","article-title":"Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia","volume":"30","author":"Ogose","year":"2001","journal-title":"Skeletal Radiol"},{"issue":"26","key":"10.1016\/j.bone.2012.11.040_bb0225","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bone.2012.11.040_bb0230","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","article-title":"Cinacalcet in the management of tumor-induced osteomalacia","volume":"22","author":"Geller","year":"2007","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212014020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212014020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T15:36:27Z","timestamp":1687880187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328212014020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S8756328212014020"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2012.11.040","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}